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Trends in Treated Drug Misuse
in the Southern Health Board Area1
Information on problem drug use is collected by the National Drug Treatment
Reporting System (NDTRS). The NDTRS is an epidemiological database on treated drug
misuse. It was established in 1990 in the Greater Dublin Area only. In 1995 it was
extended to cover other areas of the country including the Southern Health Board
(SHB) area. The objectives of the NDTRS are to provide reliable information on the
number and characteristics of people who are treated for problem drug use; and to
examine trends and patterns of problem drug use. It provides information relevant to
the health consequences and social implications of drug misuse and contributes to an
understanding of the epidemiology of drug misuse in Ireland. This series of papers
presents data by regional health board areas. 
NDTRS methodology
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Drug treatment data are viewed as an indirect indicator of drug misuse and are used
at national and European levels to provide information on the characteristics of clients
entering treatment, and patterns of drug misuse such as types of drugs used and
consumption behaviours. They are ‘valuable from a public health perspective to assess
needs, … and to plan and evaluate services’ (EMCDDA, 1998: 23). Information from
the NDTRS is made available to service providers and policy makers and forms an
important element in informing local and national drug policies. Based on NDTRS
data a number of local areas were targeted for special attention in 1996 (Ministerial
Data on treated drug misuse are routinely collected by staff at drug treatment agencies
throughout Ireland. In the SHB area data collection is co-ordinated by a Regional Co-
ordinator. Compliance with the NDTRS requires that a form be completed for each person
who receives treatment for drug use problems. At national level, anonymous, aggregated
data are compiled by the Drug Misuse Research Division, Health Research Board. 
For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to
ameliorate the psychological, medical or social state of individuals who seek help for their
drug problems’. Treatment may therefore include non-medical (addiction counselling,
group therapy, psychotherapy), as well as medical interventions (detoxification, methadone
substitution programmes).  
The main elements of the reporting system are: 
a) All Treatment Contacts – the reporting of all clients receiving treatment during a given
year, and 
b) First Treatment Contacts – the reporting of the sub-group of clients who have never
previously been treated for problem drug use.
In the case of the ‘all contact’ data there is a possibility of duplication in the database, for
example, where a person receives treatment at more than one centre. This is estimated to be
small since the introduction of the Misuse of Drugs Regulations in 1998, whereby
precautions are taken to ensure that treatment by way of medical prescription is available
from one source only.  
Treatment as an indicator of drug misuse
Task Force, 1996). Initially eleven areas, ten in Dublin and one in Cork, all of which were characterised by
social and economic disadvantage, were designated as Local Drug Task Force Areas (Ministerial Task
Force, 1996). There are now fourteen areas: twelve in Dublin; one in Cork; and one in Bray (Department
of Tourism, Sport & Recreation, 2001). Local Drug Task Forces were established with the aim of
providing strategic local responses in areas where drug misuse was a serious problem. In the
Government’s Building on Experience. National Drugs Strategy 2001-2008, the role of the NDTRS is
recognised in ensuring that the overall aims of the strategy are met. NDTRS data collection is one of the
actions identified and agreed by Government for implementation by Health Boards. It is stated that ‘all
treatment providers should co-operate in returning information on problem drug use to the DMRD of
the HRB’ (Department of Tourism, Sport & Recreation, 2001:118). 
The objective of drug policy in the SHB area is to strive for abstinence from drug use (Collins, 1999).
Drug strategies promote healthy lifestyles; and the implementation of drug prevention programmes are
encouraged and supported in schools and youth clubs throughout the area. Addiction counselling
services are provided and where possible family members are involved. Medical treatment services are
available through the Community Care Programme, and where necessary, are supported by general
practitioners, and psychiatric and general hospital services. In certain circumstances treatment places are
purchased elsewhere in order to meet needs, for example, from a specialised treatment centre for
adolescents in the South Eastern Health Board area (County Kilkenny) (Collins, 1999).  
Drug treatment services in the SHB area, reporting to the NDTRS during 2000, were provided by eight
agencies: three residential and five non-residential. Out of a total number of 429, 94 percent of clients were
treated in non-residential centres. This is a reflection of drug treatment service provision in the SHB, the aim
of which is to offer treatment on an outpatient basis. The type of drug treatment provided/availed of was
mainly advice/counselling/support (N=404). In fact the treatment provided to any one individual can be a
combination of a number of options. During 2000, as well as addiction counselling, about a quarter of
clients (N=110) received ‘medicament free/psychosocial therapy’; and another quarter (N=98) were
involved in ‘social/occupational reintegration’ programmes. Eighteen people (4 percent) underwent
detoxification, of whom 12 had used an opiate as their main drug of misuse. A very small minority of
people (N=3) were treated, as part of their treatment, in a drug substitution/maintenance programme.
Treatment provision
In the four years between 1996 and 1999 the number of drug users presenting for treatment2 in the SHB
area remained fairly stable at less than 300, fluctuating between 281 in 1996 and 258 in 1999 (Table
1a). However, this trend changed in 2000 with an increase of 66 percent, from 258 contacts in 1999 to
429 in 2000. This was due in part to an increase in service provision, and partly to an increase in drug
use. These statistics include a small number of people from outside the SHB catchment area, for example
in 2000, 7 non-residents were treated in the SHB. Almost all of those who received treatment in the SHB
during 2000 were residents of the area (422/429) (Table 1a). Altogether, 503 SHB residents were treated
for problem drug use; 16 percent of these were treated outside of the area (N=81), mainly at treatment
services in the South Eastern and Mid Western Health Board areas.
Extent of the problem
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1 Counties Cork and Kerry
2 The emphasis of this paper is on the illicit drug use of clients who received treatment between 1996 and 2000, in the catchment area covered
by the SHB (Cork & Kerry)
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More than half of those treated each year are receiving treatment for the first time (first contacts). The
number of first contacts increased from 185 in 1996 to 262 in 2000 (Table 1b).  
Table 1a. Number of All Treatment Contacts* by treatment area and area of residence of clients,
1996-2000
Year Total treated in SHB SHB residents SHB residents Others treated in Total SHB residents
treated in SHB treated elsewhere SHB treated
1996 281 276 30 5 306
1997 230 218 42 12 260
1998 263 252 51 11 303
1999 258 247 61 11 308
2000 429 422 81** 7 503**
* Number of cases, as distinct from individuals, who received treatment for their problem drug use
** Provisional figures due to incomplete returns from the ERHA health boards
Table 1b. Number of First Treatment Contacts* by treatment area and area of residence of 
clients, 1996-2000
Year Total treated in SHB SHB residents SHB residents Others treated in Total SHB residents
treated in SHB treated elsewhere SHB treated
1996 185 182 16 3 198
1997 129 122 11 7 133
1998 169 164 20 5 184
1999 149 144 24 5 168
2000 262 257 40** 5 297**
* Number of people who received treatment for the first time ever
** Provisional figures due to incomplete returns from the ERHA health boards
The typical client coming for treatment is male, in his early twenties and living in the family home.
The mean age for all clients was 25 years in 2000, somewhat older than in 1996 when it was 22 years
of age (Table 2a). Fewer clients are living with family – the proportion fell from 68 percent in 1996 to
54 percent in 2000. On closer examination of the data it emerges that more people are living alone.
In educational terms the proportion of those who had left school before the official school-leaving age
of 15 showed an increasing trend from 5 percent in 1996 to 21 percent in 2000 (Table 2a). Some of
the social conditions of clients are improving. Employment levels improved from 21 percent in 1996
to 35 percent in 2000. This is as might be expected, given the general favourable economic
conditions in the country.  
Socio-demographic information 
Table 2a. Socio-demographic characteristics of All Treatment Contacts treated in the SHB, 1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females 73:27 67:33 72:28 72:28 74:26
Mean age (years) 22 24 24 22 25
Modal age (years) 17 17 19 18 18
% Under 18 years of age 31 24 21 26 19
% Living with parents/family 68 57 64 62 54
% Early school leavers* 5 10 13 19 21
% Still at school 28 21 9 15 10
% Employed 21 22 29 25 35
* Left school before the age of 15 years
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Information on the patterns of drug use, such as the types of drugs used, how they are taken, and
whether they are taken in combination with other drugs, can be useful in assessing and planning drug
treatment services. In the Southern Health Board area cannabis is the main drug causing problems and
for which most people present for treatment (O’Brien et al. 2000). Given that cannabis is smoked, this
can have serious implications for the future health of a young population. Trends over the period 1996 to
2000 show an increase in the misuse of cannabis (Table 3a), from almost a half of all those receiving
treatment in 1996, to nearly two-thirds in 2000. In contrast to this, there was a decrease in ecstasy as
the main drug of misuse. Opiate misuse trends fluctuated from 5 percent in 1996 to 15 percent in 1997,
and 10 percent in 2000. The number of all (opiate) contacts increased from 14 in 1996 to 41 in 2000,
indicating an upward trend in opiate misuse.
Problem drug use
Trends among new clients are similar to those of the overall group of all contacts (Table 2b).
Table 3a. Main Drug of Misuse of All Treatment Contacts treated in the SHB, 1996-2000 
Main Drug of 1996 1997 1998 1999 2000
Misuse N (%) N (%) N (%) N (%) N (%)
Opiates 14 (5) 35 (15) 31 (12) 33 (13) 41 (10)
Cocaine 0 (0) 3 (1) 3 (1) 9 (3) 8 (2)
Ecstasy 85 (30) 91 (40) 81 (31) 51 (20) 62 (15)
Amphetamines 4 (1) 2 (1) 3 (1) 3 (1) 1 (0)
Benzodiazepines 10 (4) 9 (4) 13 (5) 9 (3) 18 (4)
Volatile Inhalants 4 (1) 1 (0) 7 (3) 7 (3) 7 (2)
Cannabis 138 (49) 79 (34) 109 (41) 142 (55) 278 (65)
Other substances 26 (9) 10 (4) 16 (6) 4 (2) 14 (3)
Total 281 230 263 258 429
Table 2b. Socio-demographic characteristics of First Treatment Contacts treated in the SHB, 1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females 73:27 65:35 75:25 74:26 77:23
Mean age (years) 21 23 23 20 24
Modal age (years) 16 17 17 18 20
% Under 18 years of age 35 29 25 34 24
% Living with parents/family 73 60 66 74 60
% Early school leavers* 7 5 12 18 19
% Still at school 30 27 12 22 13
% Employed 22 25 34 27 38
* Left school before the age of 15 years
Table 3b. Main Drug of Misuse of First Treatment Contacts treated in the SHB, 1996-2000 
Main Drug of 1996 1997 1998 1999 2000
Misuse N (%) N (%) N (%) N (%) N (%)
Opiates 7 (4) 11 (9) 15 (9) 11 (7) 16 (6)
Cocaine 0 (0) 2 (2) 2 (1) 5 (3) 2 (1)
Ecstasy 63 (34) 60 (47) 51 (30) 30 (20) 42 (16)
Amphetamines 3 (2) 1 (1) 2 (1) 1 (1) 1 (0)
Benzodiazepines 5 (3) 4 (3) 8 (5) 3 (2) 9 (3)
Volatile Inhalants 3 (2) 1 (1) 5 (3) 6 (4) 4 (2)
Cannabis 95 (51) 45 (35) 78 (46) 92 (62) 182 (69)
Other substances 9 (5) 5 (4) 8 (5) 1 (1) 6 (2)
Total 185 129 169 149 262
Trends were similar among the sub-group of new clients (first contacts), albeit at a slightly higher level
for cannabis and ecstasy use (Table 3b). Opiate misuse among first contacts is quite low. The number of
opiate users increased from 7 in 1996 to 16 in 2000 (Table 3b).  
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Table 4a. Opiate as a Main Drug of Misuse for All Treatment Contacts treated in the SHB, 1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin 3 15 10 16 21
of whom:
injected 0 9 7 5 12
smoked 3 5 2 11 8
other route 0 1 1 0 1
Other Opiates 11 20 21 17 20
Total 14 35 31 33 41
A closer scrutiny reveals that while heroin use is at a low level it is on the increase, from 3 in 1996 to 21
in 2000 (Table 4a). The fact that in 2000 heroin was more likely to be injected than smoked has serious
health implications. The use of other opiates increased from 11 in 1996 to 20 in 2000. The ‘other opiate’
category includes drugs such as codeine, dihydrocodeine, and methadone. 
Among new clients the number using heroin is low, but again is increasing, from 1 in 1996 to 9 in 2000
(Table 4b).
Clients are likely to be involved in the use of more than one drug (Table 5a). Trends in secondary drug
use present a picture of increasing polydrug use. In 2000 alcohol3 was reported as a secondary drug in
about one-third of cases. Although treatment for ecstasy as a main problem drug was found to be
decreasing (Table 3a), secondary drug use trends showed an increase in ecstasy use (Table 5a). In most
instances (98 percent) where ecstasy was the secondary drug, the main drug of misuse was cannabis.
This suggests an increase in the use of both cannabis and ecstasy.
Table 4b. Opiate as a Main Drug of Misuse for First Treatment Contacts treated in the SHB, 
1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin 1 5 7 5 9
of whom:
injected 0 3 4 0 5
smoked 1 2 2 5 3
other route 0 0 1 0 1
Other Opiates 6 6 8 6 7
Total 7 11 15 11 16
Table 5a. Secondary Drug of Misuse of All Treatment Contacts treated in the SHB, 1996-2000 
Secondary Drug 1996 1997 1998 1999 2000
of Misuse N (%) N (%) N (%) N (%) N (%)
No second drug 26 (9) 16 (7) 27 (10) 24 (9) 16 (4)
Opiates 7 (3) 13 (6) 2 (1) 11 (4) 19 (4)
Cocaine 1 (0) 4 (2) 5 (2) 5 (2) 17 (4)
Ecstasy 51 (18) 40 (17) 45 (17) 60 (23) 121 (28)
Amphetamines 9 (3) 8 (3) 6 (2) 10 (4) 9 (2)
Benzodiazepines 5 (2) 12 (5) 8 (3) 10 (4) 17 (4)
Volatile Inhalants 1 (0) 0 (0) 1 (0) 2 (1) 1 (0)
Cannabis 63 (22) 58 (25) 68 (26) 50 (19) 52 (12)
Alcohol 101 (36) 60 (26) 76 (29) 82 (32) 163 (38)
Other substances 17 (6) 18 (8) 25 (10) 4 (2) 14 (3)
Total 281 230* 263 258 429
* Percentages based on valid N of 229
Clients are likely
to be involved in
the use of more
than one drug
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The same trends are true for new clients (Table 5b).
Table 5b. Secondary Drug of Misuse of First Treatment Contacts treated in the SHB, 1996-2000 
Secondary Drug 1996 1997 1998 1999 2000
of Misuse N (%) N (%) N (%) N (%) N (%)
No second drug 20 (11) 12 (9) 21 (12) 15 (10) 10 (4)
Opiates 4 (2) 3 (2) 0 (0) 1 (1) 10 (4)
Cocaine 1 (1) 2 (2) 4 (2) 3 (2) 7 (3)
Ecstasy 32 (17) 22 (17) 26 (15) 38 (26) 77 (29)
Amphetamines 6 (3) 3 (2) 5 (3) 6 (4) 5 (2)
Benzodiazepines 2 (1) 4 (3) 3 (2) 2 (1) 4 (2)
Volatile Inhalants 1 (1) 0 (0) 1 (1) 1 (1) 1 (0)
Cannabis 43 (23) 38 (30) 40 (24) 29 (19) 29 (11)
Alcohol 65 (35) 35 (27) 55 (33) 54 (36) 112 (43)
Other substances 11 (6) 9 (7) 14 (8) 0 (0) 7 (3)
Total 185 129* 169 149 262
* Percentages based on valid N of 128
Over the five-year period the mean age of initial drug use was very young at 15 or 16 years of age
(Tables 6a, 6b). A relatively small number of clients (26 in 2000) had injected at some time. Injecting
practices were not presenting as a major problem – in 2000, 8 all contacts and 5 first contacts were
‘currently injecting’ (Table 6a, 6b).  
However, while the numbers who had ever injected are relatively small, the fact that an increasing
proportion of new clients are involved in injecting and sharing practices raises cause for concern and
cannot be ignored (Table 6b).  
Risk behaviour
Table 6a. Risk Behaviours of All Treatment Contacts treated in the SHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) 15 16 16 15 16
Mean age 1st injected (years) 24 21 21 18 22
Ever Injected  N 14 29 22 15 26
of whom:
‘ever shared’  N 6 9 6 3 10
‘currently injecting’  N 1 10 7 3 8
‘currently sharing’  N 0 2 2 0 2
Table 6b. Risk Behaviours of First Treatment Contacts treated in the SHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) 15 16 16 15 16
Mean age 1st injected (years) 21 25 19 20 24
Ever Injected  N 5 8 11 4 12
of whom:
‘ever shared’  N 4 3 3 0 5
‘currently injecting’  N 1 1 4 1 5
‘currently sharing’  N 0 0 1 0 1
Mean age of
initial drug use
was very young
at 15 or 16
years of age
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Figures 1a and 1b provide a comparison of the rates of treated drug misuse among residents in different
health board areas of Ireland for all and first treatment contacts respectively. As the majority of people
treated for problem drug use are in the 15-39 year age group, the rates were based on this age group of
the population in each health board area. It is immediately obvious that in the ERHA health board areas
(formerly EHB) the rate is much higher than in other regions of the country. However, there is not great
variation in regional trends. In all cases the trend shows an increase in those presenting to drug
treatment services (Figure 1a).  
There was an upward trend in first treatment contacts between 1996 and 2000 in all regions (Figure 1b).
Increased provision of services at individual health board level is of course a factor that must be borne in
mind when considering such trends. Where there are accessible drug user oriented services provided,
people are more likely to approach them. However, it would appear that the upward trends also indicate
a real increase in drug misuse.  
Regional trends
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Figure 1a. Trends in All Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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Figure 1b. Trends in First Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
Year
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Value of NDTRS
